Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease

Authors Jyothula S, Safdar Z

Published 8 September 2009 Volume 2009:4 Pages 351—363


Review by Single-blind

Peer reviewer comments 4

Soma Jyothula, Zeenat Safdar

Pulmonary-Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA

Abstract: Pulmonary hypertension (PH) is the hemodynamic manifestation of various pathological processes that result in elevated pulmonary artery pressures (PAP). The National Institutes of Health Registry defined pulmonary arterial hypertension as the mean PAP of more than 25 mm Hg with a pulmonary capillary wedge pressure or left atrial pressure equal to or less than 15 mm Hg. This definition remains the currently accepted definition of PH that is used to define PH related to multiple clinical conditions including chronic obstructive pulmonary disease (COPD). The estimated US prevalence of COPD by the National Health Survey in 2002 in people aged >25 was 12.1 million. There is a lack of large population-based studies in COPD to document the correct prevalence of PH and outcome. The major cause of PH in COPD is hypoxemia leading to vascular remodeling. Echocardiogram is the initial screening tool of choice for PH. This simple noninvasive test can provide an estimate of right ventricular systolic and right atrial pressures. Right heart catheterization remains the gold standard to diagnose PH. It provides accurate measurement of mean PAP and pulmonary capillary wedge pressure. Oxygen therapy remains the cornerstone therapeutic for hypoxemia in COPD patients. Anecdotal reports suggest utility of PDE5-inhibitors and prostacyclin to treat COPD-related PH. Large randomized clinical trials are needed before the use of these drugs can be recommended.

Keywords: pulmonary arterial hypertension, airflow obstruction, vascular remodeling

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

The relationship between cough-specific quality of life and abdominal muscle endurance, fatigue, and depression in patients with COPD

Arikan H, Savci S, Calik-Kutukcu E, Vardar-Yagli N, Saglam M, Inal-Ince D, Coplu L

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1829-1835

Published Date: 7 September 2015

Self-assembling surfactant-like peptide A6K as potential delivery system for hydrophobic drugs

Chen Y, Tang C, Zhang J, Gong M, Su B, Qiu F

International Journal of Nanomedicine 2015, 10:847-858

Published Date: 23 January 2015

The clinical use of regenerative therapy in COPD

Lipsi R, Rogliani P, Calzetta L, Segreti A, Cazzola M

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1389-1396

Published Date: 12 December 2014

Toxicity of pristine graphene in experiments in a chicken embryo model

Sawosz E, Jaworski S, Kutwin M, Hotowy A, Wierzbicki M, Grodzik M, Kurantowicz N, Strojny B, Lipińska L, Chwalibog A

International Journal of Nanomedicine 2014, 9:3913-3922

Published Date: 14 August 2014

Clinical COPD Questionnaire score (CCQ) and mortality

Sundh J, Janson C, Lisspers K, Montgomery S, Ställberg B

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:833-842

Published Date: 20 December 2012

Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease

Davood Attaran, Shahrzad M Lari, Mohammad Towhidi, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:335-340

Published Date: 30 September 2010